199 related articles for article (PubMed ID: 27227687)
1. Adaptation of liver stiffness measurement depth in bariatric surgery candidates with suspected nonalcoholic fatty liver disease.
Ciocan D; Lebrun A; Lamouri K; Pourcher G; Voican C; Njiké-Nakseu M; Ferretti S; Courie R; Tranchart H; Balian A; Prévot S; Perlemuter G; Dagher I; Naveau S
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1014-20. PubMed ID: 27227687
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
3. Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery.
Somda S; Lebrun A; Tranchart H; Lamouri K; Prevot S; Njike-Nakseu M; Gaillard M; Lainas P; Balian A; Dagher I; Perlemuter G; Naveau S; Voican CS
PLoS One; 2019; 14(5):e0217093. PubMed ID: 31125357
[TBL] [Abstract][Full Text] [Related]
4. Controlled attenuation parameter for diagnosing steatosis in bariatric surgery candidates with suspected nonalcoholic fatty liver disease.
Naveau S; Voican CS; Lebrun A; Gaillard M; Lamouri K; Njiké-Nakseu M; Courie R; Tranchart H; Balian A; Prévot S; Dagher I; Perlemuter G
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1022-1030. PubMed ID: 28570343
[TBL] [Abstract][Full Text] [Related]
5. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD.
Naveau S; Lamouri K; Pourcher G; Njiké-Nakseu M; Ferretti S; Courie R; Tranchart H; Ghinoiu M; Balian A; Prévot S; Perlemuter G; Dagher I
Obes Surg; 2014 Oct; 24(10):1693-701. PubMed ID: 24841950
[TBL] [Abstract][Full Text] [Related]
7. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.
Wong VW; Irles M; Wong GL; Shili S; Chan AW; Merrouche W; Shu SS; Foucher J; Le Bail B; Chan WK; Chan HL; de Ledinghen V
Gut; 2019 Nov; 68(11):2057-2064. PubMed ID: 30658997
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe.
Weiss J; Rau M; Meertens J; Hering I; Reichert L; Kudlich T; Koschker AK; Jurowich C; Geier A
Scand J Gastroenterol; 2016 Oct; 51(10):1263-8. PubMed ID: 27308959
[TBL] [Abstract][Full Text] [Related]
9. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V
Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533
[TBL] [Abstract][Full Text] [Related]
10. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.
Wong VW; Vergniol J; Wong GL; Foucher J; Chan AW; Chermak F; Choi PC; Merrouche W; Chu SH; Pesque S; Chan HL; de Lédinghen V
Am J Gastroenterol; 2012 Dec; 107(12):1862-71. PubMed ID: 23032979
[TBL] [Abstract][Full Text] [Related]
11. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
12. Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.
Chow JC; Wong GL; Chan AW; Shu SS; Chan CK; Leung JK; Choi PC; Chim AM; Chan HL; Wong VW
J Gastroenterol Hepatol; 2019 Jan; 34(1):241-248. PubMed ID: 29890010
[TBL] [Abstract][Full Text] [Related]
13. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan
Oeda S; Takahashi H; Imajo K; Seko Y; Ogawa Y; Moriguchi M; Yoneda M; Anzai K; Aishima S; Kage M; Itoh Y; Nakajima A; Eguchi Y
J Gastroenterol; 2020 Apr; 55(4):428-440. PubMed ID: 31654131
[TBL] [Abstract][Full Text] [Related]
15. Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study.
Wan T; Köhn N; Kröll D; Berzigotti A
Obes Surg; 2021 Feb; 31(2):702-711. PubMed ID: 32959331
[TBL] [Abstract][Full Text] [Related]
16. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
Cassinotto C; Boursier J; de Lédinghen V; Lebigot J; Lapuyade B; Cales P; Hiriart JB; Michalak S; Bail BL; Cartier V; Mouries A; Oberti F; Fouchard-Hubert I; Vergniol J; Aubé C
Hepatology; 2016 Jun; 63(6):1817-27. PubMed ID: 26659452
[TBL] [Abstract][Full Text] [Related]
17. Assessment of liver fibrosis by Fibroscan as compared to liver biopsy in biliary atresia.
Shen QL; Chen YJ; Wang ZM; Zhang TC; Pang WB; Shu J; Peng CH
World J Gastroenterol; 2015 Jun; 21(22):6931-6. PubMed ID: 26078570
[TBL] [Abstract][Full Text] [Related]
18. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.
Chan WK; Nik Mustapha NR; Mahadeva S
Hepatol Int; 2015 Oct; 9(4):594-602. PubMed ID: 25788185
[TBL] [Abstract][Full Text] [Related]
19. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
Petta S; Wong VW; Cammà C; Hiriart JB; Wong GL; Marra F; Vergniol J; Chan AW; Di Marco V; Merrouche W; Chan HL; Barbara M; Le-Bail B; Arena U; Craxì A; de Ledinghen V
Hepatology; 2017 Apr; 65(4):1145-1155. PubMed ID: 27639088
[TBL] [Abstract][Full Text] [Related]
20. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.
Conti F; Vukotic R; Foschi FG; Domenicali M; Giacomoni P; Savini S; Lanzi A; Dall'Aglio AC; Saini G; Matroroberto M; Bernardi M; Stefanini GF; Andreone P
Dig Liver Dis; 2016 Nov; 48(11):1357-1363. PubMed ID: 27522549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
